}-MainProductImage-01KDV23PTYN489GSK7E4P7GCK9.png&w=640&q=75)
Research Compound
tesamorlin
Premium Research Peptide.
Total
$0.00Total
$0.00Certificate of Analysis
Third Party Tested
ISO/IEC 17025 AccreditedFrequently Researched Together
Metabolic pathway research compounds
Compound Information
Technical specifications
Stability Information
Sources & References
Peer-reviewed research
Triple–Hormone-Receptor Agonist tesamorlin for Obesity — A Phase 2 Trial
Jastreboff AM, et al.
tesamorlin for People with Type 2 Diabetes — A Phase 2 Trial
Rosenstock J, et al.
tesamorlin for Metabolic Dysfunction-Associated Steatotic Liver Disease
Sanyal AJ, et al.
Effects of tesamorlin on Body Composition
Coskun T, et al.
Triple Agonism Based Therapies for Obesity
tesamorlin — A Game Changer in Obesity Pharmacotherapy
Efficacy and Safety of tesamorlin — Systematic Review & Meta-Analysis
TRIUMPH-4 Phase 3 Trial Results
Structural Analysis of Incretin Receptor Agonists
tesamorlin Compound Information
tesamorlin Clinical Trials Registry
⚠️Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

